Stress ulcer prophylaxis practice in UK critical care units: A comparison of cross-sectional surveys between 2020 and 2024
- PMID: 40438390
- PMCID: PMC12106379
- DOI: 10.1177/17511437251338614
Stress ulcer prophylaxis practice in UK critical care units: A comparison of cross-sectional surveys between 2020 and 2024
Abstract
Background: Critically ill patients are at risk of bleeding from stress ulcers. Comprehensive information regarding United Kingdom stress ulcer prophylaxis (SUP) practices are not available and may change over time. We aimed to describe SUP practices in 2020 and reevaluate the position in 2024.
Methods: Critical care pharmacists provided observed SUP practice data for UK adult critical care units via an electronic repository in 2020 and 2024. One response was accepted from each critical care unit at each time point. Data collected included trigger criteria for commencing SUP, primary medication class used, primary SUP cessation criteria, and level of nutritional intake (if part of cessation criteria).
Results: There were high response rates of 70.3% (2020) and 66.7% (2024) of registered UK adult critical care units. Few differences in primary SUP trigger criteria between 2020 and 2024 were seen, with small differences in the categories of 'SUP not used' (p = 0.002) and 'Shock' (p = 0.027) driving statistical significance (χ2(7, 454) = 16.76, p = 0.019). There was a significant change in the primary medication class used for SUP (H2 receptor antagonist 49.4% 2020, vs 0.4% 2024, proton pump inhibitor 44.7% 2020 vs 97.8% 2024; χ2(2, 458) = 159.62, p < 0.001). Primary SUP cessation criteria was 'Patient fed' (66.8% 2020, 64.6% 2024), with most describing this threshold as met when the patient receives full enteral feed (72.0% 2020, 78.8% 2024).
Conclusion: The UK has moved towards proton pump inhibitors as the primary SUP medication class. SUP is most frequently discontinued on establishment of enteral nutrition.
Keywords: Peptic ulcer; critical illness; enteral nutrition; histamine H2 antagonists; proton pump inhibitors.
© The Intensive Care Society 2025.
Conflict of interest statement
Greg Barton MBE receives funding for his role as an Editor-in-Chief for Critical Illness (Pharmaceutical Press). Dr Richard Bourne is funded by a National Institute for Health and Care Research (NIHR) Senior Clinical and Practitioner Research Award (NIHR304524). The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the National Institute for Health and Care Research or the Department of Health and Social Care. All other authors have declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures




References
-
- Cook D, Heyland D, Griffith L, et al.. Risk factors for clinically important upper gastrointestinal bleeding in patients requiring mechanical ventilation. Crit Care Med 1999; 27: 2812–2817. - PubMed
-
- MacLaren R, Dionne JC, Granholm A, et al.. Society of Critical Care Medicine and American Society of Health-System Pharmacists guideline for the prevention of stress-related gastrointestinal bleeding in critically ill adults. Crit Care Med 2024; 52: e421–e430. - PubMed
-
- Cook DJ, Witt LG, Cook RJ, et al.. Stress ulcer prophylaxis in the critically III: a meta-analysis. Am J Med 1991; 91: 519–527. - PubMed
-
- Cook D, Guyatt G. Prophylaxis against upper gastrointestinal bleeding in hospitalized patients. N Engl J Med 2018; 378: 2506–2516. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous